Cinfa Biotech announced trial results for a biosimilar of Amgen’s Neulasta, a multi-billion blockbuster to treat chemotherapy-induced neutropenia. Cinfa Biotech is a Spanish company specialized in developing biosimilars. The biotech
Tag "Spain"
Spain’s pharmaceutical market set to show signs of stability, surpassing $25 billion by 2021, says GlobalData. The Spanish pharmaceutical market is set to see a slight rise in value from
A medical team from Clínica Universidad de Navarra in Pamplona has successfully performed Spain’s first implant of the SynCardia temporary Total Artificial Heart. The 47-year-old patient, was suffering from severe